Effect of Helicobacter pylori eradication on reflux esophagitis therapy: A multi-center randomized control study

Chinese Medical Journal

Volumn 128, Issue 8, 2015, Pages 995-999

  Xue, Yan ^a   Zhou, Li Ya ^a   Lin, San Ren ^a   Hou, Xiao Hua ^b   Li, Zhao Shen ^c   Chen, Min Hu ^d   Yan, Xiu E ^a   Meng, Ling Mei ^a   Zhang, Jing ^a   Lu, Jing Jing ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

Gastroesophageal reflux disease; Helicobacter pylori; Reflux esophagitis; Therapy

Indexed keywords

AMOXICILLIN; ESOMEPRAZOLE; TINIDAZOLE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENDOSCOPY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HEARTBURN; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RAPID UREASE TEST; REFLUX ESOPHAGITIS; THORAX PAIN; ADOLESCENT; COMPLICATION; DRUG EFFECTS; ESOPHAGITIS, PEPTIC; HELICOBACTER INFECTIONS; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AMOXICILLIN; ESOMEPRAZOLE; ESOPHAGITIS, PEPTIC; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; TINIDAZOLE; YOUNG ADULT;

EID: 84929069644     PISSN: 03666999     EISSN: 25425641     Source Type: Journal    
DOI: 10.4103/0366-6999.155049     Document Type: Article

References (16)

1. Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, et al. Second Asia-Pacific consensus guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009;24:1587-600.
2. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2013;108:308-28.
3. Polat FR, Polat S. The effect of Helicobacter pylori on gastroesophageal reflux disease. JSLS 2012;16:260-3.
4. Xie T, Cui X, Zheng H, Chen D, He L, Jiang B. Meta-analysis: Eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 2013;25:1195-205.
5. Ramus JR, Gatenby PA, Caygill CP, Watson A. Helicobacter pylori infection and severity of reflux-induced esophageal disease in a cohort of patients with columnar-lined esophagus. Dig Dis Sci 2007;52:2821-5.
6. Fallone CA, Barkun AN, Mayrand S, Wakil G, Friedman G, Szilagyi A, et al. There is no difference in the disease severity of gastro-oesophageal reflux disease between patients infected and not infected with Helicobacter pylori. Aliment Pharmacol Ther 2004;20:761-8.
7. Den Hollander WJ, Sostres C, Kuipers EJ, Lanas A. Helicobacter pylori and nonmalignant diseases. Helicobacter 2013;18 Suppl 1:24-7.
8. Hirata K, Suzuki H, Matsuzaki J, Masaoka T, Saito Y, Nishizawa T, et al. Improvement of reflux symptom related quality of life after Helicobacter pylori eradication therapy. J Clin Biochem Nutr 2013;52:172-8.
9. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection – The Maastricht IV/Florence Consensus Report. Gut 2012;61:646-64.
10. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20.
11. Souza RC, Lima JH. Helicobacter pylori and gastroesophageal reflux disease: A review of this intriguing relationship. Dis Esophagus 2009;22:256-63.
12. Wu JC, Chan FK, Wong SK, Lee YT, Leung WK, Sung JJ. Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis. Aliment Pharmacol Ther 2002;16:545-52.
13. Delaney B, McColl K. Review article: Helicobacter pylori and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005;22 Suppl 1:32-40.
14. Calleja JL, Suarez M, De Tejada AH, Navarro A, Pantogerd Group. Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole. Dig Dis Sci 2005;50:432-9.
15. Tefera S, Hatlebakk JG, Berstad AE, Berstad A. Eradication of Helicobacter pylori does not increase acid reflux in patients with mild to moderate reflux oesophagitis. Scand J Gastroenterol 2002;37:877-83.
16. De Boer W, de Wit N, Geldof H, Hazelhoff B, Bergmans P, Smout A, et al. Does Helicobacter pylori infection influence response rate or speed of symptom control in patients with gastroesophageal reflux disease treated with rabeprazole? Scand J Gastroenterol 2006;41:1147-54.